SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant volatility following its latest earnings report, where a solid top-and-bottom-line beat was overshadowed by investor apprehension regarding a planned $40 billion financing initiative. While the community remains divided between those viewing the aggressive capital expenditure as a necessary fuel for accelerating AI infrastructure demand and those concerned about the resulting debt and potential share dilution, sentiment is heavily influenced by intense trading activity and frustration over the stock's unpredictable post-earnings swings.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing heightened volatility and intense community debate as the ETF trades below its 200-day moving average, prompting many investors to weigh its traditional role as a safe haven against recent bearish price action. Traders are actively discussing whether this decline is a major correction in a long-term bull market or a sign that gold is losing its effectiveness as an inflation hedge amidst rising interest rate expectations and fluctuating geopolitical tensions.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is facing intense volatility as the community remains sharply divided over the company's financial future, with ongoing discussions focusing on the impact of geopolitical conflicts, domestic inflation data, and concerns regarding corporate leadership. Investors are actively debating the viability of the platform while frequently referencing broader market trends and the company's long-term operational outlook.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is experiencing significant volatility and investor debate following a new distribution agreement with NBCUniversal that restores access to key channels. While some investors see this as a long-awaited catalyst for growth and a potential setup for a short squeeze, many others remain skeptical, pointing to historical management performance and concerns over consistent profitability.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is experiencing extreme volatility and intense community debate as investors react to a significant price decline, with many traders labeling the leveraged ETF a high-risk "decay trap" while others attempt to scalp the volatility. Sentiment is polarized, pitting those who see a value buying opportunity during market pullbacks against those who warn of the dangers of holding a 2x leveraged product amid ongoing share price erosion.

Tidal Trust II - Defiance Daily Target 2X Short SMCI ETF

Defiance Daily Target 2X Short SMCI ETF

The Defiance Daily Target 2X Short SMCI ETF (SMCZ) is seeing intense trading activity as investors react to ongoing volatility and negative headlines surrounding Super Micro Computer. The community is actively debating the merits of playing this leveraged inverse ETF to hedge against pullbacks, with many traders focusing on aggressive day trading strategies while others warn about the risks of holding these instruments long-term due to their daily reset mechanics.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as investors debate its long-term viability amid concerns over stalled technical execution and institutional sell-offs, even as some community members highlight the company's operational progress and potential for future growth. The community remains sharply divided, with bulls pointing to FAA milestone achievements and strategic defense partnerships while bears express skepticism regarding the lack of piloted transition flights and the potential for further price downside.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing significant volatility driven by heavy short interest and concerns over the dilution necessary to fund aggressive M&A, though long-term investors are actively buying the dip to support the CEO's growth thesis. Community sentiment is deeply divided between those frustrated by recent price declines and those aggressively scaling positions in anticipation of a potential short squeeze and future margin expansion.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) remains a focal point as investors weigh persistent geopolitical tensions in the Middle East against a broader market rotation out of high-valuation AI and semiconductor stocks. Community discussion is heavily split between concerns over inflationary pressures and the potential for a defensive shift into industrial value names amid ongoing market volatility.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. (SWMR) is trending as traders speculate on potential dilution following a recent shelf offering, sparking intense debate between bulls citing long-term defense contracts and bears criticizing the lack of revenue. Community members are actively split, with some highlighting the company's autonomous drone technology as a sector-leading "gold mine" while others label the price action as a volatile pump-and-dump scheme.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Amgen's MariTide Win Share in the Fast-Growing Obesity Market?

MariTide's less frequent dosing could help AMGN carve out a place in the rapidly expanding obesity drug market.

Here are Wednesday's biggest analyst calls: Nvidia, Tesla, Cava, Netflix, Chipotle, Pfizer, Nike, SharkNinja & more

Here are the biggest calls on Wall Street on Wednesday...

Viral Influencer: How Bill Gates' Billions Shape US Medical Research

Viral Influencer: How Bill Gates' Billions Shape US Medical Research

 Authored by Paul D. Thacker via RealClearInvestigations,

Bill Gates has long been one of the most admired people in the world, especially since he stepped down from his role running Microsoft to devote himself and...

PFE Gets FDA Nod for Expanded Use of Hemophilia Drug Hympavzi

Pfizer wins FDA approval to expand Hympavzi's use in additional hemophilia A and B patient groups, including children with inhibitors.

The $100 Billion Oncology Opportunity Investors are Starting to Notice

Artificial intelligence continues to dominate healthcare headlines, but another transformative story is quietly unfolding across biotechnology: the race to develop more effective treatments for some of the deadliest forms of cancer. From precision oncology and targeted therapies to next-generation approaches designed to overcome treatment resistance, a new wave of innovation is emerging that could reshape cancer care over the next decade. $NTHI, $GSK, $NUVL, $PFE, $RHHBY, $BMY

Pfizer's Obesity Drug Shows 16% Weight Loss In Phase 2b Study

Pfizer reports Phase 2b obesity drug data showing 15.9% weight loss as FDA expands HYMPAVZI use for hemophilia patients.read more...

Can Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer.

Can Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer...

Pfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems

Pfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems...

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizers GLP-1 RA Berobenatide

Pfizer Inc. (NYSE: PFE) today presented detailed results from multiple Phase 2b studies of berobenatide (PF3944), an investigational, potential first-in-class monthly GLP-1 receptor agonist (GLP-1 RA) peptide, during a late-breaking expert symposium at the 86th Scientific Sessions of the American...

Why Is Pfizer (PFE) Down 4.5% Since Last Earnings Report?

Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

This account has been verified as an official PFE representative.

Verified Account

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

SMMT Stock Surges Overnight: Cancer Drug Survival Win Raises The Bar As PFE, BMY, MRK Chase Keytruda's Successor

Equity

Bullish Sentiment

Track PFE stock price, charts, news and real-time market activity on Stocktwits. Join the PFE message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Pfizer Inc stock.

PFEPfizer Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PFE News